Topics › Drug Policy
Commentary by Adrian Moore and Jacob James Rich
Testimony by Geoffrey Lawrence
Backgrounder by Leonard Gilroy and Geoffrey Lawrence
Commentary by Layal Bou Harfouch
Testimony by Madison Carlino
Psychedelics Policy Newsletter by Gregory Ferenstein
Commentary by Gregory Ferenstein
Commentary by Michelle Minton and Geoffrey Lawrence